Evidence map›Paper›PMID 22422287›Full record

ArticleCerebellum (London, England)2012

Sequence analysis of 5' regulatory regions of the Machado-Joseph disease gene (ATXN3).

Conceição Bettencourt, Mafalda Raposo, Nadiya Kazachkova, Cristina Santos, Teresa Kay, João Vasconcelos, Patrícia Maciel, Karina C Donis, Maria Luiza Saraiva-Pereira, Laura B Jardim and 3 more

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Cerebellum (London, England), 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.4field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 9 institutions in 4 countries.

Conceição BettencourtInstitute for Molecular and Cell Biology (IBMC), University of Porto, Porto, Portugal. mcbettencourt@uac.pt
Mafalda Raposo
Nadiya Kazachkova
Cristina Santos
Teresa Kay
João Vasconcelos
Patrícia Maciel
Karina C Donis
Maria Luiza Saraiva-Pereira
Laura B Jardim
Jorge Sequeiros
Jácome Bruges-Armas
Manuela Lima
Hospital de Clínicas de Porto Alegre · BRUniversidade do Porto · PTUniversidade dos Açores · PTHospital de Dona Estefânia · PTHospital de Santo Espirito de Angra do Heroísmo · PTHospital do Divino Espírito Santo · PTInstitut de Biologie Moléculaire et Cellulaire · FRUniversitat Autònoma de Barcelona · ESUniversity of Minho · PT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Machado-Joseph disease (MJD) is a late-onset autosomal dominant neurodegenerative disorder, which is caused by a coding (CAG)(n) expansion in the ATXN3 gene (14q32.1). The number of CAG repeats in the expanded alleles accounts only for 50 to 75 % of onset variance, the remaining variation being dependent on other factors. Differential allelic expression of ATXN3 could contribute to the explanation of different ages at onset in patients displaying similar CAG repeat sizes. Variation in 5' regulatory regions of the ATXN3 gene may have the potential to influence expression levels and, ultimately, modulate the MJD phenotype. The main goal of this work was to analyze the extent of sequence variation upstream of the ATXN3 start codon. A fragment containing the core promoter and the 5' untranslated region (UTR) was sequenced and analyzed in 186 patients and 59 controls (490 chromosomes). In the core promoter, no polymorphisms were observed. In the 5' UTR, only one SNP (rs3814834) was found, but no improvements on the explanation of onset variance were observed, when adding its allelic state in a linear model. Accordingly, in silico analysis predicted that this SNP lays in a nonconserved position for CMYB binding. Therefore, no functional effect could be predicted for this variant.

Indexed as

AdolescentAdultAgedAllelesAtaxin-3ChildFemaleGenetic VariationHumansMachado-Joseph DiseaseMaleMiddle AgedNerve Tissue ProteinsNuclear ProteinsPhenotypePolymorphism, GeneticAtaxin-3ATXN3 protein, humanNerve Tissue ProteinsNuclear ProteinsRepressor Proteins

Identifiers

PMID22422287
OpenAlexW1965532423

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.